Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure

摘要

BackgroundLevosimendan has pharmacologic and hemodynamic advantages over conventional intravenous inotropic agents. It has been used mainly as a rescue drug in the pediatric intensive care unit or in the operating room. We present the largest single-center experience of levosimendan in children.